Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1213 of 5804
-
New pill takes aim at Hard-to-Treat cancers
Disease control Recruiting nowThe goal of this clinical trial is to learn if an investigational drug CP-383 works to treat advanced cancer. It will also learn about the safety of CP-383. The main questions if aims to answer are: * Does CP-383 slow or stop the growth of cancer in patients with advanced cancer…
Phase: PHASE1, PHASE2 • Sponsor: Tasca Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
Could a wearable device spark recovery in chronic stroke patients?
Symptom relief Recruiting nowThis trial tests a promising new intervention to promote post-stroke neural reorganization and functional recovery. The Q Therapeutic (BQ 3.0) is a wearable medical system that produces and delivers non-invasive, extremely-low-intensity and low-frequency, frequency-tuned electrom…
Phase: NA • Sponsor: University of Florida • Aim: Symptom relief
Last updated Jul 04, 2026 00:00 UTC
-
New hope for frail seniors with head and neck cancer: easier treatment regimen tested
Disease control Recruiting nowThis is a study conducted in patients with a diagnosis of stage IB-IVA squamous cell carcinoma of the head and neck. Patients will have a comprehensive geriatric assessment (CGA) as part of standard assessments. The patients classified as frail, with a CGA score of 3-5, will then…
Phase: PHASE3 • Sponsor: Brown University • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
New hope for rare skin cancer: experimental drug enters human trial
Disease control Recruiting nowThis is a single-center, phase I/IB study to identify the recommended phase II dose of Ropeginterferon-alfa 2b (P1101) in patients with CTCL who have failed at least two prior lines of skin-directed therapy (Stage IA-IB) or have less than a complete response to phototherapy or ex…
Phase: PHASE1 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
Your phone could soon spot a hidden heart condition
Diagnosis ENROLLING_BY_INVITATIONThe purpose of this 4-in-1 observational study is to test the performance of artificial intelligences (AIs) in distinguishing irregularly irregular heart rhythm called atrial fibrillation (AF) from normal heart rhythm using physiological signals collected by smartphones' built-in…
Sponsor: The University of Hong Kong • Aim: Diagnosis
Last updated Jun 27, 2026 08:07 UTC
-
New drug litfulo tracked in 3,000 patients for hair loss treatment
Disease control Recruiting nowThe purpose of this observation study is to learn about the safety and effects of the study medicine (called Litfulo) for the potential treatment of Severe Alopecia Areata.
Sponsor: Pfizer • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
New shot could tame tough eczema in phase 2 trial
Disease control OngoingThe goal of this interventional study is to learn if TRIV-509 works to treat moderate to severe atopic dermatitis in adults. It will also evaluate the safety of TRIV-509. Participants will receive 4 doses of the study intervention that they are randomized to (TRIV-509 or placebo…
Phase: PHASE2 • Sponsor: Triveni Bio • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
New study tests clotting drug to stop dangerous bleeding after birth
Disease control Recruiting nowThis study will look at how safe is the medicine eptacog alfa when used in women in India for stopping heavy bleeding after giving birth. If participants have heavy bleeding after giving birth then they will get the medicine eptacog alfa. This study will be conducted to get more …
Phase: PHASE4 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
Tribal schools test culturally smart program to keep kids healthy
Prevention Recruiting nowThe goal of this study is to learn if a culturally relevant health promotion curricula prevents obesity among 4th graders in rural tribal schools. The main questions it aims to answer are: 1) Does the health promotion curricula intervention increase diet and physical activity beh…
Phase: NA • Sponsor: Northern Arizona University • Aim: Prevention
Last updated Jun 27, 2026 07:59 UTC
-
New combo therapy aims to stop rare bone cancer from spreading
Disease control Recruiting nowThis is a prospective, single-arm, single-center clinical trial designed to evaluate the safety and efficacy of radiation combined with a BCMA/CD3 bispecific antibody (CM336) in patients with solitary bone plasmacytoma (SBP) with mild bone marrow infiltration.
Phase: PHASE2 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Jun 26, 2026 14:59 UTC
-
New drug aimed at kidney disease shows promise in early trial
Disease control Recruiting nowTo evaluate the safety and tolerability of three dose regimens of budoprutug in subjects with PMN
Phase: PHASE2 • Sponsor: Climb Bio, Inc. • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
First gene therapy injection targets rare brain disorder
Disease control ENROLLING_BY_INVITATIONThis is gene therapy study of an AAV9 vector carrying the SLCA1 gene for SLC6A1 neurodevelopmental disorder.
Phase: PHASE1, PHASE2 • Sponsor: Emily de los Reyes • Aim: Disease control
Last updated Jun 26, 2026 17:08 UTC
-
New cancer drug TJ101 enters first human trials for advanced tumors
Disease control Recruiting nowThe goal of this clinical trial is to evaluate whether TJ101, an investigational antibody-drug conjugate (ADC), can safely and effectively treat patients with advanced solid tumors. The main objectives of this study are : * To Determine the maximum tolerated dose (MTD) and reco…
Phase: PHASE1 • Sponsor: Phrontline Biopharma • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
Cancer immunotherapy may weaken bones, new study warns
Knowledge-focused Recruiting nowImmune checkpoint inhibitors (ICIs) have revolutionized cancer treatment and work by blocking protein interactions that normally prevent the immune system from recognizing and destroying cancer cells. However, these agents, now approved for over 15 types of cancers and for both e…
Phase: NA • Sponsor: Jessica Mezzanotte Sharpe • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:30 UTC
-
New injection shows promise for shedding pounds in early trial
Disease control Recruiting nowThis is a multicenter, double-blind, randomized, placebo-controlled phase Ⅱ study to evaluate the efficacy, safety, pharmacokinetics, and immunogenicity of YN-011 in subjects with overweight (27 kg/m2 ≤ BMI \< 30 kg/m2, with at least one comorbidity) or obesity (BMI ≥ 30 kg/m2, w…
Phase: PHASE2 • Sponsor: Shanghai Yinnuo Pharmaceutical Technology Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
Brain zaps may tame sensory overload in kids with autism
Symptom relief ENROLLING_BY_INVITATIONThe goal of this clinical trial is to find out if brain stimulation can help improve sensory integration in children ages 6 to 12 with autism spectrum disorder (ASD). The main questions it aims to answer are: Does brain stimulation using continuous theta-burst stimulation (cTBS)…
Phase: NA • Sponsor: Neurolab Plus • Aim: Symptom relief
Last updated Jun 26, 2026 19:17 UTC
-
New shingles drug brivudine aims to beat standard treatment in pain battle
Disease control Recruiting nowThis multicenter RCT aims to compare the efficacy and safety of Brivudine versus Famciclovir in treating acute herpes zoster. Primary objective: Evaluate pain reduction via Numeric Pain Rating Scale (NPRS) at Day 30. Secondary objectives: Compare NPRS at Day 3/Day 7/Day 14/Day 90…
Phase: PHASE4 • Sponsor: Peking University Third Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
New lupus drug YK012 enters human trials – hope for patients?
Disease control Recruiting nowThe goal of this clinical trial is to evaluate the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD), and preliminary efficacy of YK012 in participants with Moderate to Severe Systemic Lupus Erythematosus (SLE).
Phase: PHASE1, PHASE2 • Sponsor: Excyte Biopharma Ltd • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
Promising combo therapy for aggressive prostate cancer tested before surgery
Disease control TerminatedA randomized, open-label Phase I/II study of neoadjuvant treatment with \[177Lu\]Lu-PSMA-617 radioligandtherapy (LuPSMA) with or without Ipilimumab in participants with very high-risk prostate cancer who are candidates for Radical Prostatectomy.
Phase: PHASE1, PHASE2 • Sponsor: University Hospital, Essen • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
Could a Marijuana-Derived drug help treat sleep apnea?
Disease control Recruiting nowThis is an open-label trial that tests the effectiveness of Dronabinol in treating obstructive sleep apnea (OSA). All participants will take oral Dronabinol for two weeks. Sleep studies will be conducted before and after treatment to measure OSA severity.
Phase: PHASE1, PHASE2 • Sponsor: VA Office of Research and Development • Aim: Disease control
Last updated Jun 26, 2026 16:26 UTC